Innovating for Health: The Story of Baxter International |
Contents
Making a Tough Investment Decision | 2 |
The Baton is Passed | 15 |
The Early Years 193139 | 39 |
Copyright | |
15 other sections not shown
Common terms and phrases
Abbott acquisition Alternate American Hospital Supply annual approach artificial kidney Baxter and American Baxter International Baxter Laboratories Baxter management Baxter sales Bays became began Bill Graham CAPD Caremark Chicago clinical common stock company's competitive continued corporate cost decision Deerfield dextrose dialysis distribution Don Baxter drug early earnings eighties employees END NOTES CHAPTER executive Factor VIII Fenwal Gantz global going growth Harry Falk health care system hemodialysis hemophiliacs industry initial innovation intravenous investment Jim Tobin Johnson & Johnson Kimbell Lambrix later leadership long-term major manufacturing McGaw meeting ment merger million Morton Grove Nawoj Nesset Oddi operating patient percent peritoneal peritoneal dialysis pharmaceutical plant plastic position problems profit Ralph Falk share solutions strategy successful suppliers tion Tobin Transfuso Vac Travenol U.S. hospital Vern Loucks Viaflex container vice president Wee Willie Keeler